Approval · Notice of Compliance 12054 · 2011
NUVARING: Notice of Compliance 12054
Issued February 10, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12054
- Date
- February 10, 2011
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Contraceptive vaginal ring
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUVARING | 02253186 | Marketed |
Medicinal ingredients
- ETONOGESTREL 11.4 MG per RING
- ETHINYL ESTRADIOL 2.6 MG per RING